{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:41:09Z","timestamp":1788903669032,"version":"build-2803163510"},"reference-count":114,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["R01HL049277"],"award-info":[{"award-number":["R01HL049277"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Diabetic nephropathy (DN), defined as continuously elevated urinary albumin and a diminished estimated glomerular filtration rate, is a serious complication of both type 1 diabetes and type 2 diabetes and is the main cause of end-stage kidney disease. Patients with end-stage renal disease require chronic kidney dialysis and\/or a kidney transplantation. Research highlights the role of diet in modulating specific signaling pathways that are instrumental in the progression of DN. Nutrient-sensitive pathways, affected by nutritional compounds and dietary components, offer a novel perspective on the management of DN by influencing inflammation, oxidative stress, and nutrient metabolism. Animal models have identified signaling pathways related to glucose metabolism, inflammation responses, autophagy, and lipid metabolism, while human population studies have contributed to the clinical significance of designing medical and nutritional therapies to attenuate DN progression. Here, we will update recent progress in research into the renoprotective or therapeutic effects of nutritional compounds, and potential nutrition-modulated pathways.<\/jats:p>","DOI":"10.3390\/nu16121918","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T03:42:06Z","timestamp":1718682126000},"page":"1918","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Nutritional Strategies against Diabetic Nephropathy: Insights from Animal Studies and Human Trials"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7301-2698","authenticated-orcid":false,"given":"Jiayi","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Franceschini","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. H. Davin","family":"Townley-Tilson","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyo","family":"Maeda-Smithies","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA"},{"name":"Department of Pathology and Laboratory Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2147\/IJNRD.S40172","article-title":"Diabetic nephropathy\u2014Complications and treatment","volume":"7","author":"Lim","year":"2014","journal-title":"Int. J. Nephrol. Renovasc Dis."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Irazabal, M.V., and Torres, V.E. (2020). Reactive Oxygen Species and Redox Signaling in Chronic Kidney Disease. Cells, 9.","DOI":"10.3390\/cells9061342"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2022.03.019","article-title":"Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectives","volume":"184","author":"Bhatti","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Cabala, S., Ozgo, M., and Herosimczyk, A. (2024). The Kidney-Gut Axis as a Novel Target for Nutritional Intervention to Counteract Chronic Kidney Disease Progression. Metabolites, 14.","DOI":"10.3390\/metabo14010078"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1681\/ASN.2013080905","article-title":"The gut microbiome, kidney disease, and targeted interventions","volume":"25","author":"Ramezani","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2337\/diaspect.28.3.181","article-title":"Nutrition Intervention for Advanced Stages of Diabetic Kidney Disease","volume":"28","year":"2015","journal-title":"Diabetes Spectr."},{"key":"ref_7","first-page":"9","article-title":"Administration of antioxidants in chronic kidney disease","volume":"4","author":"Tamadon","year":"2015","journal-title":"J. Nephropharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Dennis, J.M., and Witting, P.K. (2017). Protective Role for Antioxidants in Acute Kidney Disease. Nutrients, 9.","DOI":"10.3390\/nu9070718"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1681\/ASN.2004070612","article-title":"Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db\/db mice","volume":"16","author":"Chow","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"L1069","DOI":"10.1152\/ajplung.00408.2005","article-title":"Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: Role of NADPH oxidase and endothelial NO synthase","volume":"290","author":"Grobe","year":"2006","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_11","unstructured":"Li, X., Zhang, Y., Xing, X., Li, M., Liu, Y., Xu, A., and Zhang, J. (2023). Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects. Biomed. Pharmacother., 168."},{"key":"ref_12","first-page":"19","article-title":"Insulin and insulin resistance","volume":"26","author":"Wilcox","year":"2005","journal-title":"Clin. Biochem. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"18701","DOI":"10.3402\/jchimp.v2i2.18701","article-title":"History of insulin","volume":"21","author":"Quianzon","year":"2012","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cmet.2009.03.012","article-title":"AMPK: An emerging drug target for diabetes and the metabolic syndrome","volume":"9","author":"Zhang","year":"2009","journal-title":"Cell Metab."},{"key":"ref_15","first-page":"1","article-title":"METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARdelta-dependent pathways in skeletal muscle of mice","volume":"50","author":"Jung","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/febs.15301","article-title":"The myokine meteorin-like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKalpha2","volume":"287","author":"Lee","year":"2020","journal-title":"FEBS J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"E751","DOI":"10.1152\/ajpendo.00745.2009","article-title":"AMPK and SIRT1: A long-standing partnership?","volume":"298","author":"Ruderman","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2021.02.065","article-title":"Liraglutide regulates lipid metabolism via FGF21-LKB1-AMPK-ACC1 pathway in white adipose tissues and macrophage of type 2 diabetic mice","volume":"548","author":"Zhang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cell.2014.03.065","article-title":"Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis","volume":"157","author":"Rao","year":"2014","journal-title":"Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"108443","DOI":"10.1016\/j.diabres.2020.108443","article-title":"Correlation of serum meteorin-like concentrations with diabetic nephropathy","volume":"169","author":"Wang","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2337\/db22-0680","article-title":"Metrnl Alleviates Lipid Accumulation by Modulating Mitochondrial Homeostasis in Diabetic Nephropathy","volume":"72","author":"Zhou","year":"2023","journal-title":"Diabetes"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.cmet.2020.10.019","article-title":"Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism","volume":"32","author":"Fu","year":"2020","journal-title":"Cell Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fendo.2019.00155","article-title":"The Discovery and Development of Liraglutide and Semaglutide","volume":"10","author":"Knudsen","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"104778","DOI":"10.1016\/j.phrs.2020.104778","article-title":"Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis","volume":"156","author":"Su","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Avila-Carrasco, L., Garcia-Mayorga, E.A., Diaz-Avila, D.L., Garza-Veloz, I., Martinez-Fierro, M.L., and Gonzalez-Mateo, G.T. (2021). Potential Therapeutic Effects of Natural Plant Compounds in Kidney Disease. Molecules, 26.","DOI":"10.3390\/molecules26206096"},{"key":"ref_26","unstructured":"Gao, S., Siddiqui, N., Etim, I., Du, T., Zhang, Y., and Liang, D. (2021). Developing nutritional component chrysin as a therapeutic agent: Bioavailability and pharmacokinetics consideration, and ADME mechanisms. Biomed. Pharmacother., 142."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Oriquat, G., Masoud, I.M., Kamel, M.A., Aboudeya, H.M., Bakir, M.B., and Shaker, S.A. (2023). The Anti-Obesity and Anti-Steatotic Effects of Chrysin in a Rat Model of Obesity Mediated through Modulating the Hepatic AMPK\/mTOR\/lipogenesis Pathways. Molecules, 28.","DOI":"10.3390\/molecules28041734"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Tao, H., Xu, N., Zhou, S., Peng, Y., Zhu, J., Liu, S., and Chang, Y. (2022). Chrysin improves diabetic nephropathy by regulating the AMPK-mediated lipid metabolism in HFD\/STZ-induced DN mice. J. Food Biochem., 46.","DOI":"10.1111\/jfbc.14379"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Salehi, B., Mishra, A.P., Nigam, M., Sener, B., Kilic, M., Sharifi-Rad, M., Fokou, P.V.T., Martins, N., and Sharifi-Rad, J. (2018). Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines, 6.","DOI":"10.3390\/biomedicines6030091"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.2741\/4885","article-title":"Resveratrol improves lipid metabolism in diabetic nephropathy rats","volume":"25","author":"Zhao","year":"2020","journal-title":"Front. Biosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.diabres.2016.12.005","article-title":"Resveratrol ameliorates hyperglycemia-induced renal tubular oxidative stress damage via modulating the SIRT1\/FOXO3a pathway","volume":"126","author":"Wang","year":"2017","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7296092","DOI":"10.1155\/2016\/7296092","article-title":"SIRT1\/3 Activation by Resveratrol Attenuates Acute Kidney Injury in a Septic Rat Model","volume":"2016","author":"Xu","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Ruhee, R.T., and Suzuki, K. (2020). The Integrative Role of Sulforaphane in Preventing Inflammation, Oxidative Stress and Fatigue: A Review of a Potential Protective Phytochemical. Antioxidants, 9.","DOI":"10.3390\/antiox9060521"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1042\/CS20191088","article-title":"Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function","volume":"134","author":"Li","year":"2020","journal-title":"Clin. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/s12020-022-03002-1","article-title":"Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury","volume":"76","author":"Cai","year":"2022","journal-title":"Endocrine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.R036012","article-title":"The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism","volume":"54","author":"Groen","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"106367","DOI":"10.1016\/j.phrs.2022.106367","article-title":"Inulin-type fructans change the gut microbiota and prevent the development of diabetic nephropathy","volume":"183","author":"Luo","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/advances\/nmab119","article-title":"The Prebiotic Potential of Inulin-Type Fructans: A Systematic Review","volume":"13","author":"Hughes","year":"2022","journal-title":"Adv. Nutr."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1007\/s00125-007-0791-0","article-title":"Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia","volume":"50","author":"Cani","year":"2007","journal-title":"Diabetologia"},{"key":"ref_40","unstructured":"Tougaard, N.H., Frimodt-Moller, M., Salmenkari, H., Stougaard, E.B., Zawadzki, A.D., Mattila, I.M., Hansen, T.W., Legido-Quigley, C., Horkko, S., and Forsblom, C. (2022). Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial. J. Clin. Med., 11."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1161\/CIRCRESAHA.122.320184","article-title":"Faecalibacterium prausnitzii Attenuates CKD via Butyrate-Renal GPR43 Axis","volume":"131","author":"Li","year":"2022","journal-title":"Circ. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/ndt\/gfy238","article-title":"Sodium butyrate ameliorates insulin resistance and renal failure in CKD rats by modulating intestinal permeability and mucin expression","volume":"34","author":"Gonzalez","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.kint.2020.01.028","article-title":"Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease","volume":"97","author":"Gryp","year":"2020","journal-title":"Kidney Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41467-019-09735-4","article-title":"Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease","volume":"10","author":"Kikuchi","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.diabres.2008.09.053","article-title":"Serum indoxyl sulfate levels in patients with diabetic nephropathy: Relation to renal function","volume":"83","author":"Atoh","year":"2009","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/ndt\/gfq580","article-title":"p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease","volume":"26","author":"Wu","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Menez, S., Hanouneh, M., Shafi, T., and Jaar, B.G. (2019). Indoxyl sulfate is associated with mortality after AKI\u2014More evidence needed!. BMC Nephrol., 20.","DOI":"10.1186\/s12882-019-1465-0"},{"key":"ref_48","first-page":"126","article-title":"Serum Levels of Indoxyl Sulfate and P-cresol in Type II Diabetic Patients with and without Nephropathy","volume":"17","author":"Aliasgharzadeh","year":"2023","journal-title":"Iran. J. Kidney Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2017.09.018","article-title":"Using binding competitors of albumin to promote the removal of protein-bound uremic toxins in hemodialysis: Hope or pipe dream?","volume":"144","author":"Florens","year":"2018","journal-title":"Biochimie"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/CIRCULATIONAHA.119.039818","article-title":"Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients","volume":"139","author":"Jukema","year":"2019","journal-title":"Circulation"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1681\/ASN.2019101029","article-title":"Dietary Fiber Protects against Diabetic Nephropathy through Short-Chain Fatty Acid-Mediated Activation of G Protein-Coupled Receptors GPR43 and GPR109A","volume":"31","author":"Li","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.7150\/thno.40571","article-title":"Dysbiosis of intestinal microbiota mediates tubulointerstitial injury in diabetic nephropathy via the disruption of cholesterol homeostasis","volume":"10","author":"Hu","year":"2020","journal-title":"Theranostics"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Magliocca, G., Mone, P., Di Iorio, B.R., Heidland, A., and Marzocco, S. (2022). Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23105354"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI0215219","article-title":"1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system","volume":"110","author":"Li","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"F301","DOI":"10.1152\/ajprenal.00471.2009","article-title":"Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats","volume":"298","author":"Park","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12020-017-1402-6","article-title":"The cellular selection between apoptosis and autophagy: Roles of vitamin D, glucose and immune response in diabetic nephropathy","volume":"58","author":"Hamzawy","year":"2017","journal-title":"Endocrine"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s11255-020-02728-z","article-title":"Vitamin D protects glomerular mesangial cells from high glucose-induced injury by repressing JAK\/STAT signaling","volume":"53","author":"Yang","year":"2021","journal-title":"Int. Urol. Nephrol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.metabol.2014.06.013","article-title":"The PI3K\/p-Akt signaling pathway participates in calcitriol ameliorating podocyte injury in DN rats","volume":"63","author":"Song","year":"2014","journal-title":"Metabolism"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","article-title":"Vitamin D metabolism, mechanism of action, and clinical applications","volume":"21","author":"Bikle","year":"2014","journal-title":"Chem. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.arcmed.2013.02.002","article-title":"Vitamin D receptor gene polymorphisms and type 2 diabetes: A meta-analysis","volume":"44","author":"Li","year":"2013","journal-title":"Arch. Med. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"7941861","DOI":"10.1155\/2020\/7941861","article-title":"Autophagy and mTOR Pathways Mediate the Potential Renoprotective Effects of Vitamin D on Diabetic Nephropathy","volume":"2020","author":"Khodir","year":"2020","journal-title":"Int. J. Nephrol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1042\/CS20210625","article-title":"Mechanisms of podocyte injury and implications for diabetic nephropathy","volume":"136","author":"Barutta","year":"2022","journal-title":"Clin. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/15548627.2021.1962681","article-title":"Vitamin D-VDR (vitamin D receptor) regulates defective autophagy in renal tubular epithelial cell in streptozotocin-induced diabetic mice via the AMPK pathway","volume":"18","author":"Li","year":"2022","journal-title":"Autophagy"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2515690X221116403","DOI":"10.1177\/2515690X221116403","article-title":"Vitamin D Supplementation Could Enhance the Effectiveness of Glibenclamide in Treating Diabetes and Preventing Diabetic Nephropathy: A Biochemical, Histological and Immunohistochemical Study","volume":"27","author":"Atia","year":"2022","journal-title":"J. Evid. Based Integr. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2010.09.026","article-title":"Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress","volume":"40","author":"Sengupta","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s004030050444","article-title":"The action of a novel vitamin D3 analogue, OCT, on immunomodulatory function of keratinocytes and lymphocytes","volume":"291","author":"Komine","year":"1999","journal-title":"Arch. Dermatol. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"F1107","DOI":"10.1152\/ajprenal.00151.2012","article-title":"Loss of vitamin D receptor in chronic kidney disease: A potential mechanism linking inflammation to epithelial-to-mesenchymal transition","volume":"303","author":"Xiong","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_69","first-page":"1215","article-title":"The effects of calcitriol on albuminuria in patients with type-2 diabetes mellitus","volume":"23","author":"Bonakdaran","year":"2012","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.dsx.2018.11.008","article-title":"The effects of vitamin D supplementation on lipid profiles and oxidative indices among diabetic nephropathy patients with marginal vitamin D status","volume":"13","author":"Barzegari","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_71","first-page":"374","article-title":"Whether vitamin D3 is effective in reducing proteinuria in type 2 diabetic patients?","volume":"18","author":"Ahmadi","year":"2013","journal-title":"J. Res. Med. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e13381","DOI":"10.5812\/numonthly.13381","article-title":"The effect of calcium with or without calcitriol supplementation on renal function in patients with hypovitaminosis d and chronic kidney disease","volume":"6","author":"Mustafar","year":"2014","journal-title":"Nephrourol. Mon."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.dsx.2019.01.043","article-title":"The association between 25-hydroxy vitamin D deficiency and diabetic complications in patients with type 2 diabetes mellitus","volume":"13","author":"Senyigit","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/j.dsx.2019.04.040","article-title":"Vitamin D status in diabetic patients (type 2) and its relation to glycemic control & diabetic nephropathy","volume":"13","author":"Ali","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"10","DOI":"10.15171\/jnp.2017.03","article-title":"Effect of vitamin D on proteinuria in type 2 diabetic patients","volume":"6","author":"Momeni","year":"2017","journal-title":"J. Nephropathol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ki.2011.224","article-title":"Oral cholecalciferol decreases albuminuria and urinary TGF-beta1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition","volume":"80","author":"Kim","year":"2011","journal-title":"Kidney Int."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Kawanami, D., Takashi, Y., and Tanabe, M. (2020). Significance of Metformin Use in Diabetic Kidney Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124239"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","year":"2024","journal-title":"Kidney Int."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1039\/C5FO01530H","article-title":"Dietary protein intake and human health","volume":"7","author":"Wu","year":"2016","journal-title":"Food Funct."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Tanaka, S., Wakui, H., Azushima, K., Tsukamoto, S., Yamaji, T., Urate, S., Suzuki, T., Abe, E., Taguchi, S., and Yamada, T. (2023). Effects of a High-Protein Diet on Kidney Injury under Conditions of Non-CKD or CKD in Mice. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24097778"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"103308","DOI":"10.1016\/j.isci.2021.103308","article-title":"Kidney disease risk factors do not explain impacts of low dietary protein on kidney function and structure","volume":"24","author":"Fotheringham","year":"2021","journal-title":"iScience"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"16026","DOI":"10.1038\/cddiscovery.2016.26","article-title":"Is low-protein diet a possible risk factor of malnutrition in chronic kidney disease patients?","volume":"2","author":"Noce","year":"2016","journal-title":"Cell Death Discov."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/MCO.0000000000000342","article-title":"Dietary protein intake and chronic kidney disease","volume":"20","author":"Ko","year":"2017","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.34067\/KID.0001002022","article-title":"Protein Restriction for CKD: Time to Move On","volume":"3","author":"Obeid","year":"2022","journal-title":"Kidney360"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1053\/j.ajkd.2008.12.014","article-title":"Dietary protein restriction in CKD: The debate continues","volume":"53","author":"Ikizler","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"ref_87","first-page":"CD014906","article-title":"Protein restriction for diabetic kidney disease","volume":"1","author":"Jiang","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e3150","DOI":"10.1002\/dmrr.3150","article-title":"Protein intake is not associated with progression of diabetic kidney disease in patients without macroalbuminuria","volume":"35","author":"Kaji","year":"2019","journal-title":"Diabetes Metab. Res. Rev."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Zha, Y., and Qian, Q. (2017). Protein Nutrition and Malnutrition in CKD and ESRD. Nutrients, 9.","DOI":"10.3390\/nu9030208"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.jrn.2018.12.005","article-title":"High-Resistant Starch, Low-Protein Flour Intervention on Patients with Early Type 2 Diabetic Nephropathy: A Randomized Trial","volume":"29","author":"Meng","year":"2019","journal-title":"J. Ren. Nutr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-nutr-071714-034426","article-title":"Long-Term Effects of High-Protein Diets on Renal Function","volume":"37","author":"Kamper","year":"2017","journal-title":"Annu. Rev. Nutr."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Aziz, M., Jalilpiran, Y., Nekouimehr, M., Fattahi, S., Mokhtari, P., Jayedi, A., Yekaninejad, M.S., and Mirzaei, K. (2021). Dietary protein sources and risk of diabetic nephropathy in women: A case-control study. BMC Endocr. Disord., 21.","DOI":"10.1186\/s12902-021-00841-3"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"183","DOI":"10.23876\/j.krcp.20.163","article-title":"Implications of oxidative stress in chronic kidney disease: A review on current concepts and therapies","volume":"40","author":"Verma","year":"2021","journal-title":"Kidney Res. Clin. Pract."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00592-023-02125-9","article-title":"Dose-response relationship between dietary antioxidant intake and diabetic kidney disease in the US adults with diabetes","volume":"60","author":"Zhang","year":"2023","journal-title":"Acta Diabetol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/fft2.15","article-title":"Dietary polyphenols as antidiabetic agents: Advances and opportunities","volume":"1","author":"Sun","year":"2020","journal-title":"Food Front."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/advances\/nmaa075","article-title":"Resveratrol: Evidence for Its Nephroprotective Effect in Diabetic Nephropathy","volume":"11","author":"Gowd","year":"2020","journal-title":"Adv. Nutr."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11010-015-2576-y","article-title":"Resveratrol prevents renal lipotoxicity in high-fat diet-treated mouse model through regulating PPAR-alpha pathway","volume":"411","author":"Zhou","year":"2016","journal-title":"Mol. Cell Biochem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00109-016-1451-y","article-title":"Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK\/NOX4\/ROS pathway","volume":"94","author":"He","year":"2016","journal-title":"J. Mol. Med."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Cao, Y.L., Lin, J.H., Hammes, H.P., and Zhang, C. (2022). Flavonoids in Treatment of Chronic Kidney Disease. Molecules, 27.","DOI":"10.3390\/molecules27072365"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1039\/D3FO00242J","article-title":"Dietary flavonoid intake is associated with a lower risk of diabetic nephropathy in US adults: Data from NHANES 2007\u20132008, 2009\u20132010, and 2017\u20132018","volume":"14","author":"Liu","year":"2023","journal-title":"Food Funct."},{"key":"ref_101","first-page":"CD006763","article-title":"Altered dietary salt intake for preventing diabetic kidney disease and its progression","volume":"1","author":"Hodson","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1507\/endocrj.EJ21-0447","article-title":"Impact of salt intake on urinary albumin excretion in patients with type 2 diabetic nephropathy: A retrospective cohort study based on a generalized additive model","volume":"69","author":"Kotake","year":"2022","journal-title":"Endocr. J."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41598-020-79687-z","article-title":"Relationship between basal sodium intake and the effects of dapagliflozin in albuminuric diabetic kidney disease","volume":"11","author":"Kinguchi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Chewcharat, A., Chewcharat, P., Rutirapong, A., and Papatheodorou, S. (2020). The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0228315"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.21873\/invivo.13282","article-title":"Dietary Intake of Polyunsaturated Fatty Acids and Diabetic Nephropathy: Cohort Analysis of the Tsugaru Study","volume":"37","author":"Nakamura","year":"2023","journal-title":"In Vivo"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2337\/dc19-0412","article-title":"Associations Between Linoleic Acid Intake and Incident Type 2 Diabetes among U.S. Men and Women","volume":"42","author":"Zong","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e127660","DOI":"10.1172\/jci.insight.127660","article-title":"Engulfment and cell motility protein 1 potentiates diabetic cardiomyopathy via Rac-dependent and Rac-independent ROS production","volume":"4","author":"Kakoki","year":"2019","journal-title":"JCI Insight"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.2147\/IJGM.S440103","article-title":"Association of Apolipoprotein E Gene Polymorphism with Type 2 Diabetic Nephropathy in the Southern Chinese Population","volume":"16","author":"Gan","year":"2023","journal-title":"Int. J. Gen. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1155\/2009\/797601","article-title":"XbaI GLUT1 gene polymorphism and the risk of type 2 diabetes with nephropathy","volume":"27","author":"Stefanidis","year":"2009","journal-title":"Dis. Markers"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13073-023-01209-z","article-title":"Ancestry-driven metabolite variation provides insights into disease states in admixed populations","volume":"15","author":"Reynolds","year":"2023","journal-title":"Genome Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.36922\/ijb.1862","article-title":"Achieving personalized nutrition for patients with diabetic complications via 3D food printing","volume":"10","author":"Chen","year":"2024","journal-title":"IJB"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.21037\/atm-2020-117","article-title":"Paving the way to precision medicine for diabetic kidney disease: The PRIORITY trial","volume":"8","author":"Schechter","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Yang, L., Wu, L., Fan, Y., and Ma, J. (2017). Vitamin D receptor gene polymorphisms in association with diabetic nephropathy: A systematic review and meta-analysis. BMC Med. Genet., 18.","DOI":"10.1186\/s12881-017-0458-8"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1128\/MCB.20.18.6704-6711.2000","article-title":"Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase","volume":"20","author":"Woods","year":"2000","journal-title":"Mol. Cell Biol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/12\/1918\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:00:17Z","timestamp":1760108417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/12\/1918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":114,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["nu16121918"],"URL":"https:\/\/doi.org\/10.3390\/nu16121918","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,18]]}}}